AI assistant
Sending…
NEKTAR THERAPEUTICS — Director's Dealing 2021
Aug 27, 2021
32134_dirs_2021-08-26_506b48fc-b75d-49d9-bb85-0e2b47e0d8bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2021-08-24
Reporting Person: CHESS ROBERT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-24 | Common Stock | G | 6300 | $0.00 | Disposed | 274273 | Direct |
| 2021-08-24 | Common Stock | G | 2100 | $0.00 | Acquired | 2100 | Indirect |
| 2021-08-24 | Common Stock | G | 2100 | $0.00 | Acquired | 2100 | Indirect |
| 2021-08-24 | Common Stock | G | 2100 | $0.00 | Acquired | 2100 | Indirect |
Footnotes
F1: This transaction involved a gift of shares by the reporting person to his children.
F2: The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
More from NEKTAR THERAPEUTICS
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Capital/Financing Update
2026
May 8
Annual Report
2026
Apr 24
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20